-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Guangyuyuan replied to investors on the investor interaction platform that from April 1, 2022, the retail price of the company's Angong Niuhuang Pills (boutique series, iron box) will be adjusted to: 980 yuan / pill, Angong Niuhuang Pills The retail price of pills (boutique series, wooden box) is adjusted to: 1680 yuan per pill, due to the influence of rising raw material prices
.
It is reported that this is the second time that Guangyuyuan has raised prices this year
.
The last time was on January 15, 2022, and the retail price of Angong Niuhuang Pills (Double Natural) (3g/pill) was set at 880 yuan/pill
.
Recently, I have often heard the news of the price increase of traditional Chinese medicine, such as Jiuzhitang, Tongrentang, China Resources Sanjiu, Zhongxin Pharmaceutical, Taiji Industry and other companies have raised the price of some products
.
Among them, in January this year, Jiuzhitang issued a price adjustment notice to customers, and the prices of more than 20 kinds of proprietary Chinese medicines were raised, and the market's expectations for the improvement of the traditional Chinese medicine sector continued to heat up
.
It is reported that Jiuzhitang has raised the supply price or retail price of its 21 Chinese patent medicines, involving Liuwei Dihuang Pills, Xiaoyao Pills, Angong Niuhuang Pills and other products, and the price increase of some products is as high as 30%
.
The ex-factory price of Tai Chi Group's Huoxiang Zhengqi Oral Liquid was raised by 12%
.
Beijing Tongrentang’s Angong Niuhuang Pills (3g*1 box) will increase the price from 780 yuan to 860 yuan; China Resources Sanjiu said at the end of 2021 that it will increase the ex-factory price of Angong Niuhuang Pills
.
According to relevant data, as of December 31, 2021, the market (annual) index of Chinese medicinal materials in many places has increased by 13%-15%
.
Among them, the market in Haozhou increased by 14.
91%
.
In addition, according to relevant reports, there are more than 2,600 varieties of Chinese herbal medicines in the Bozhou Chinese herbal medicine market in Anhui, of which more than 60% of the varieties have experienced price increases to varying degrees
.
Among the Chinese herbal medicines whose prices have increased, the price of Rehmannia glutinosa has increased by 293.
93%, and the current price ranges from 50 yuan to 58 yuan per kilogram
.
As for why the price of traditional Chinese medicine has risen, the industry said that the rise in raw material prices, the shortage of market supply, the upgrade of comprehensive costs and consumption, and the price comparison effect between competing products may all be the reasons for the rise in products.
.
The Huaan Securities Research Report pointed out that the price index of Chinese herbal medicines has continued to increase since 2019, especially after 2020, seasonal factors, cyclical factors, and multi-factor expansion of supply gaps and other factors have contributed to the continuous increase in prices
.
Overall, the price of Chinese herbal medicines is still rising this year
.
However, some people believe that the price increase of Chinese medicinal materials is being transmitted to the downstream drug side
.
"The increase in the price of Chinese medicinal materials has increased the cost of raw material procurement and operational difficulties for downstream pharmaceutical companies
.
Large companies rely on capital advantages and cost control, terminal prices increase, and consumers pay
.
Small companies will face the double blow of cost and brand, and life will be even more difficult
.
In addition, some analysts said that the general increase in Chinese medicinal materials has led to a general increase in the production cost of Chinese patent medicines
.
It pointed out that the increase in the production cost of Chinese patent medicines is mainly due to the substantial increase in the cost of Chinese herbal medicine raw materials, followed by the increase in the cost of excipients and packaging and labor costs
.
The person predicts that the price of Chinese herbal medicines is expected to remain high in 2022, and will become a key factor in the upward production cost of Chinese patent medicines
.
For solving the dilemma of rising prices of Chinese herbal medicines, some people in the industry suggest that, first, we should work with multiple ministries to establish a price detection and adjustment mechanism for Chinese herbal medicines and improve relevant regulations; The Chinese herbal medicine planting base, promote the operation mode of Chinese herbal medicine cooperatives at the grass-roots level; 3.
Expand the high-quality emerging production areas of Chinese herbal medicines; related details,
etc.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
It is reported that this is the second time that Guangyuyuan has raised prices this year
.
The last time was on January 15, 2022, and the retail price of Angong Niuhuang Pills (Double Natural) (3g/pill) was set at 880 yuan/pill
.
Recently, I have often heard the news of the price increase of traditional Chinese medicine, such as Jiuzhitang, Tongrentang, China Resources Sanjiu, Zhongxin Pharmaceutical, Taiji Industry and other companies have raised the price of some products
.
Among them, in January this year, Jiuzhitang issued a price adjustment notice to customers, and the prices of more than 20 kinds of proprietary Chinese medicines were raised, and the market's expectations for the improvement of the traditional Chinese medicine sector continued to heat up
.
It is reported that Jiuzhitang has raised the supply price or retail price of its 21 Chinese patent medicines, involving Liuwei Dihuang Pills, Xiaoyao Pills, Angong Niuhuang Pills and other products, and the price increase of some products is as high as 30%
.
The ex-factory price of Tai Chi Group's Huoxiang Zhengqi Oral Liquid was raised by 12%
.
Beijing Tongrentang’s Angong Niuhuang Pills (3g*1 box) will increase the price from 780 yuan to 860 yuan; China Resources Sanjiu said at the end of 2021 that it will increase the ex-factory price of Angong Niuhuang Pills
.
According to relevant data, as of December 31, 2021, the market (annual) index of Chinese medicinal materials in many places has increased by 13%-15%
.
Among them, the market in Haozhou increased by 14.
91%
.
In addition, according to relevant reports, there are more than 2,600 varieties of Chinese herbal medicines in the Bozhou Chinese herbal medicine market in Anhui, of which more than 60% of the varieties have experienced price increases to varying degrees
.
Among the Chinese herbal medicines whose prices have increased, the price of Rehmannia glutinosa has increased by 293.
93%, and the current price ranges from 50 yuan to 58 yuan per kilogram
.
As for why the price of traditional Chinese medicine has risen, the industry said that the rise in raw material prices, the shortage of market supply, the upgrade of comprehensive costs and consumption, and the price comparison effect between competing products may all be the reasons for the rise in products.
.
The Huaan Securities Research Report pointed out that the price index of Chinese herbal medicines has continued to increase since 2019, especially after 2020, seasonal factors, cyclical factors, and multi-factor expansion of supply gaps and other factors have contributed to the continuous increase in prices
.
Overall, the price of Chinese herbal medicines is still rising this year
.
However, some people believe that the price increase of Chinese medicinal materials is being transmitted to the downstream drug side
.
"The increase in the price of Chinese medicinal materials has increased the cost of raw material procurement and operational difficulties for downstream pharmaceutical companies
.
Large companies rely on capital advantages and cost control, terminal prices increase, and consumers pay
.
Small companies will face the double blow of cost and brand, and life will be even more difficult
.
In addition, some analysts said that the general increase in Chinese medicinal materials has led to a general increase in the production cost of Chinese patent medicines
.
It pointed out that the increase in the production cost of Chinese patent medicines is mainly due to the substantial increase in the cost of Chinese herbal medicine raw materials, followed by the increase in the cost of excipients and packaging and labor costs
.
The person predicts that the price of Chinese herbal medicines is expected to remain high in 2022, and will become a key factor in the upward production cost of Chinese patent medicines
.
For solving the dilemma of rising prices of Chinese herbal medicines, some people in the industry suggest that, first, we should work with multiple ministries to establish a price detection and adjustment mechanism for Chinese herbal medicines and improve relevant regulations; The Chinese herbal medicine planting base, promote the operation mode of Chinese herbal medicine cooperatives at the grass-roots level; 3.
Expand the high-quality emerging production areas of Chinese herbal medicines; related details,
etc.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
